Publication
GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function
Downloadable Content
- Persistent URL
- Last modified
- 03/05/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2017-06-01
- Publisher
- Nature Publishing Group: Open Access Hybrid Model Option B
- Publication Version
- Copyright Statement
- © 2017 The Japan Society of Human Genetics. All rights reserved.
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 1434-5161
- Volume
- 62
- Issue
- 6
- Start Page
- 589
- End Page
- 597
- Grant/Funding Information
- TMP and CS were funded by the Cedars-Sinai institutional funding program and the Cedars-Sinai Diana and Steve Marienhoff Fashion Industries Guild Endowed Fellowship in Pediatric Neuromuscular Diseases.
- During this work, WC was supported by the Xiangya-Emory Medical Schools Visiting Student Program; HY was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH-R01HD082373, by the Emory +Children’s Pediatric Center Seed Grant Program, by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454, by NIH HHSN268201400169P; SFT was supported by NIH-NINDS R01NS036654, R24NS092989 and R01NS092989.
- Abstract
- N-methyl-d-aspartate receptors (NMDARs) play important roles in brain development and neurological disease. We report two individuals with similar dominant de novo GRIN1 mutations (c.1858 G > A and c.1858 G > C; both p.G620R). Both individuals presented at birth with developmental delay and hypotonia associated with behavioral abnormalities and stereotypical movements. Recombinant NMDARs containing the mutant GluN1-G620R together with either GluN2A or GluN2B were evaluated for changes in their trafficking to the plasma membrane and their electrophysiological properties. GluN1-G620R/GluN2A complexes showed a mild reduction in trafficking, a ∼2-fold decrease in glutamate and glycine potency, a strong decrease in sensitivity to Mg 2+ block, and a significant reduction of current responses to a maximal effective concentration of agonists. GluN1-G620R/GluN2B complexes showed significantly reduced delivery of protein to the cell surface associated with similarly altered electrophysiology. These results indicate these individuals may have suffered neurodevelopmental deficits as a result of the decreased presence of GluN1-G620R/GluN2B complexes on the neuronal surface during embryonic brain development and reduced current responses of GluN1-G620R-containing NMDARs after birth. These cases emphasize the importance of comprehensive functional characterization of de novo mutations and illustrates how a combination of several distinct features of NMDAR expression, trafficking and function can be present and influence phenotype.
- Author Notes
- Keywords
- Research Categories
- Biology, Neuroscience
- Biology, Genetics
- Health Sciences, Pharmacology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - s602g.pdf | Primary Content | 2025-03-04 | Public | Download |